Related Experiment Video
Updated: May 14, 2026
07:34
FISH for Pre-implantation Genetic Diagnosis
Published on: February 23, 2011
Teratogen screening: state of the art
1Faculty of Veterinary Medicine, Institute of Physiological Chemistry, University of Leipzig, Leipzig, Germany.
Avicenna Journal of Medical Biotechnology
|February 15, 2013
Summary
New chemicals require rapid detection of developmental toxicity. This review discusses current in vitro methods, their pros and cons, and ideal test system requirements for teratogenicity testing.
Area of Science:
- Environmental toxicology
- Developmental biology
- Chemical safety assessment
Background:
- Increasing environmental chemical exposure necessitates efficient toxicity detection.
- Traditional in vivo animal testing faces challenges in speed, cost, and ethics.
- Developmental toxicity assessment is crucial due to potential long-term health impacts.
Purpose of the Study:
- To review existing in vitro techniques for detecting developmental toxicity.
- To outline the requirements for an ideal in vitro teratogenicity test system.
- To critically evaluate the advantages and disadvantages of current in vitro methods.
Main Methods:
- Comprehensive literature review of established in vitro developmental toxicity assays.
- Analysis of criteria for an optimal in vitro teratogenicity testing system.
- Comparative assessment of existing in vitro methodologies.
Main Results:
- Several in vitro techniques have been developed as alternatives to animal testing.
- No single in vitro method currently meets all ideal requirements for teratogenicity testing.
- Each method presents unique advantages and limitations regarding sensitivity, specificity, and cost.
Conclusions:
- In vitro methods offer promising alternatives for developmental toxicity screening.
- Further refinement and validation are needed to establish ideal in vitro teratogenicity test systems.
- A combination of in vitro approaches may be necessary for comprehensive risk assessment.
Related Concept Videos
01:07Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
02:46Genetic Screens
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...